Review



k252a  (Tocris)


Bioz Verified Symbol Tocris is a verified supplier
Bioz Manufacturer Symbol Tocris manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 93

    Structured Review

    Tocris k252a
    K252a, supplied by Tocris, used in various techniques. Bioz Stars score: 93/100, based on 110 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/k-252a/K+252a/pm41922794-355-4-8
    Average 93 stars, based on 110 article reviews
    k252a - by Bioz Stars, 2026-11
    93/100 stars

    Images

    Related Articles

    other:

    Article Title: Hippocampal SENP3 mediates chronic stress-induced depression-like behaviors by impairing the CREB-BDNF signaling.
    Article Snippet: Impaired signaling between cyclic adenosine monophosphate response element binding protein (CREB) and brain-derived neurotrophic factor (BDNF) in the hippocampus is generally considered to be the cause of depression.. The mechanisms underlying the impairment of CREB-BDNF signaling under stress conditions are largely unclear.. Small ubiquitin-like modifier (SUMO) specific peptidase 3 (SENP3) is a molecule that can regulate SUMOylation of target proteins related to synaptic plasticity.

    Article Title: Protease activated receptor-1 regulates mixed lineage kinase-3 to drive triple-negative breast cancer tumorigenesis.
    Article Snippet: The pan MLK inhibitor, CEP-1347, was procured from Tocris Biosciences, Minneapolis, MN.

    Article Title: Cannabinoid overrides triggers of GABAergic plasticity in vestibular circuits and distorts the development of navigation
    Article Snippet: K252a ((9S,10R,12R)-2,3,9,10,11,12-hexahydro-10-hydroxy-9-methyl-1-oxo-9,12-epoxy-1H-diindolo[1,2,3-fg:3′,2',1′-kl]pyrrolo[3,4-i][1,6]benzodiazocine-10-carboxylic acid methyl ester) , Tocris Bioscience 1683/200U , .

    Control:

    Article Title: Reduced SH3RF3 may protect against Alzheimer’s disease by lowering microglial pro-inflammatory responses via modulation of JNK and NFkB signaling
    Article Snippet: .. In some experiments, iMGLs were pre-treated with chemical inhibitors or DMSO vehicle for 2 hr before inflammatory stimuli, which included CEP-1347 (100 nM; Tocris), IKK16 (1 uM; Tocris), and NSC23766 (50 uM; EMD Millipore). iMGLs were then treated with either the dsRNA viral mimic poly(I:C) at (25 ug/mL) , oligomerized Aβ42 (5 uM; rPeptide), or vehicle control (dH 2 O or F12 media respectively). .. Recombinant Aβ42 was oligomerized as described previously, and validated via Coomassie blue staining and western blot using the 6E10 antibody (1:1000; BioLegend).



    Similar Products

    95
    MedChemExpress agents k252a
    Agents K252a, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/k-252a/K-252a/pm41872517-54-2-16
    Average 95 stars, based on 1 article reviews
    agents k252a - by Bioz Stars, 2026-11
    95/100 stars
      Buy from Supplier

    93
    Tocris k252a
    K252a, supplied by Tocris, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/k-252a/K+252a/pm41922794-355-4-8
    Average 93 stars, based on 1 article reviews
    k252a - by Bioz Stars, 2026-11
    93/100 stars
      Buy from Supplier

    95
    MedChemExpress k252a
    BDNF/TrkB regulate the abilities of cell proliferation, migration and invasion in KYSE-150 cells. (A and B) CCK-8 assay checked cell proliferation affected by hrBDNF and <t>k252a;</t> (C and D) plate cloning assay analyzed cloning formation ability of KYSE-150 cell affected by hrBDNF and k252a; (E–H) the abilities of cell invasion and migration affected by hrBDNF and k252a evaluated by scratch wound healing assays and Boyden chamber migration and invasion assays; and (I) the expression of MMP9, N-cadherin, S100B, and NGF affected by hBDNF and k252a with WB. * p < 0.05, ** p < 0.01, and *** p < 0.001.
    K252a, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/k-252a/K-252a/pmc13003859-120-5-15
    Average 95 stars, based on 1 article reviews
    k252a - by Bioz Stars, 2026-11
    95/100 stars
      Buy from Supplier

    95
    MedChemExpress k252a hy n6732
    BDNF/TrkB regulate the abilities of cell proliferation, migration and invasion in KYSE-150 cells. (A and B) CCK-8 assay checked cell proliferation affected by hrBDNF and <t>k252a;</t> (C and D) plate cloning assay analyzed cloning formation ability of KYSE-150 cell affected by hrBDNF and k252a; (E–H) the abilities of cell invasion and migration affected by hrBDNF and k252a evaluated by scratch wound healing assays and Boyden chamber migration and invasion assays; and (I) the expression of MMP9, N-cadherin, S100B, and NGF affected by hBDNF and k252a with WB. * p < 0.05, ** p < 0.01, and *** p < 0.001.
    K252a Hy N6732, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/k-252a/K-252a/10__1016_slash_j__jfutfo__2025__08__027-96-1-23
    Average 95 stars, based on 1 article reviews
    k252a hy n6732 - by Bioz Stars, 2026-11
    95/100 stars
      Buy from Supplier

    Image Search Results


    BDNF/TrkB regulate the abilities of cell proliferation, migration and invasion in KYSE-150 cells. (A and B) CCK-8 assay checked cell proliferation affected by hrBDNF and k252a; (C and D) plate cloning assay analyzed cloning formation ability of KYSE-150 cell affected by hrBDNF and k252a; (E–H) the abilities of cell invasion and migration affected by hrBDNF and k252a evaluated by scratch wound healing assays and Boyden chamber migration and invasion assays; and (I) the expression of MMP9, N-cadherin, S100B, and NGF affected by hBDNF and k252a with WB. * p < 0.05, ** p < 0.01, and *** p < 0.001.

    Journal: Cancer Biology & Therapy

    Article Title: Deguelin inhibits perineural invasion in esophageal squamous cell carcinoma via targeting BDNF/TrkB axis

    doi: 10.1080/15384047.2026.2644788

    Figure Lengend Snippet: BDNF/TrkB regulate the abilities of cell proliferation, migration and invasion in KYSE-150 cells. (A and B) CCK-8 assay checked cell proliferation affected by hrBDNF and k252a; (C and D) plate cloning assay analyzed cloning formation ability of KYSE-150 cell affected by hrBDNF and k252a; (E–H) the abilities of cell invasion and migration affected by hrBDNF and k252a evaluated by scratch wound healing assays and Boyden chamber migration and invasion assays; and (I) the expression of MMP9, N-cadherin, S100B, and NGF affected by hBDNF and k252a with WB. * p < 0.05, ** p < 0.01, and *** p < 0.001.

    Article Snippet: Recombined human BDNF protein (Cat#450-02), k252a (Cat#HY-N6732), and Deguelin (Cat#HY-13425) were obtained from PeproTech and Med Chem Express (MCE), respectively.

    Techniques: Migration, CCK-8 Assay, Cloning, Expressing

    BDNF/TrkB regulate the interaction between DRG and KYSE-150 cells. (A–C) The distance of ESCC cell migration and the numbers of newborn ganglion synapses in the DRG-ESCC cells co-culture model treated with BDNF and k252a, respectively. Scale bar: 100 μM; green arrow: newborn ganglion synapses; yellow arrow: KYSE-150 cell. *** p < 0.001.

    Journal: Cancer Biology & Therapy

    Article Title: Deguelin inhibits perineural invasion in esophageal squamous cell carcinoma via targeting BDNF/TrkB axis

    doi: 10.1080/15384047.2026.2644788

    Figure Lengend Snippet: BDNF/TrkB regulate the interaction between DRG and KYSE-150 cells. (A–C) The distance of ESCC cell migration and the numbers of newborn ganglion synapses in the DRG-ESCC cells co-culture model treated with BDNF and k252a, respectively. Scale bar: 100 μM; green arrow: newborn ganglion synapses; yellow arrow: KYSE-150 cell. *** p < 0.001.

    Article Snippet: Recombined human BDNF protein (Cat#450-02), k252a (Cat#HY-N6732), and Deguelin (Cat#HY-13425) were obtained from PeproTech and Med Chem Express (MCE), respectively.

    Techniques: Migration, Co-Culture Assay

    The role of BDNF/TrkB in ESCC PNI development in vivo . (A) The experimental flowchart of the PNI model treated with 500 μg/kg and 750 μg/kg k252a ( n = 5/group); (B and C) representative images and quantitative analysis of PNI development assessed with IVIS Spectrum in vivo imaging system; (D) representative images and quantitative analysis of the xenograft tumor in the PNI models treated with k252a; (E) representative images of the PNI model checking with HE and IHC with S100B and SCCA1; (F) The occurrence rate of PNI treated with k252a; (G–I) WB analysis and quantitative analysis of the protein expression of N-cadherin, MMP9, NGF and S100B during PNI development (40-, 50-, 60-d) and in the PNI models of the control and k252a-treated groups; (J) WB and quantitative analysis of the expression of BDNF and TrkB during PNI progress with CDX and PNI models. Red arrow: ESCC cells; black arrow: neuron; scale bar: 50 μM; * p < 0.05, ** p < 0.01, and *** p < 0.001.

    Journal: Cancer Biology & Therapy

    Article Title: Deguelin inhibits perineural invasion in esophageal squamous cell carcinoma via targeting BDNF/TrkB axis

    doi: 10.1080/15384047.2026.2644788

    Figure Lengend Snippet: The role of BDNF/TrkB in ESCC PNI development in vivo . (A) The experimental flowchart of the PNI model treated with 500 μg/kg and 750 μg/kg k252a ( n = 5/group); (B and C) representative images and quantitative analysis of PNI development assessed with IVIS Spectrum in vivo imaging system; (D) representative images and quantitative analysis of the xenograft tumor in the PNI models treated with k252a; (E) representative images of the PNI model checking with HE and IHC with S100B and SCCA1; (F) The occurrence rate of PNI treated with k252a; (G–I) WB analysis and quantitative analysis of the protein expression of N-cadherin, MMP9, NGF and S100B during PNI development (40-, 50-, 60-d) and in the PNI models of the control and k252a-treated groups; (J) WB and quantitative analysis of the expression of BDNF and TrkB during PNI progress with CDX and PNI models. Red arrow: ESCC cells; black arrow: neuron; scale bar: 50 μM; * p < 0.05, ** p < 0.01, and *** p < 0.001.

    Article Snippet: Recombined human BDNF protein (Cat#450-02), k252a (Cat#HY-N6732), and Deguelin (Cat#HY-13425) were obtained from PeproTech and Med Chem Express (MCE), respectively.

    Techniques: In Vivo, In Vivo Imaging, Expressing, Control

    BDNF/TrkB regulated ESCC PNI through Akt signaling. (A) Representative images and fluorescence intensity of the PNI model treated with k252a using IVIS spectrum in vivo imaging system ( n = 3/group); (B) representative images and quantitative analysis of the xenograft tumor in PNI models treated with k252a; (C) the clustering diagram of differentially expressed genes (DEGs) analyzed by transcriptome sequencing with xenograft tumor tissues from the k252a·PNI groups and PNI groups; (D) pathway analysis of downregulated DEGs using the GO database; (E and F) the mRNA expression levels of Akt in the PNI and k252a·PNI groups, CDX, and PNI groups using qRT-PCR; and (G–J) WB and quantitative analysis of the protein expression levels of Akt and pAkt in the PNI and k252a·PNI groups and the CDX and PNI groups at 40-, 50-, and 60-d. * p < 0.05, ** p < 0.01, and *** p < 0.001.

    Journal: Cancer Biology & Therapy

    Article Title: Deguelin inhibits perineural invasion in esophageal squamous cell carcinoma via targeting BDNF/TrkB axis

    doi: 10.1080/15384047.2026.2644788

    Figure Lengend Snippet: BDNF/TrkB regulated ESCC PNI through Akt signaling. (A) Representative images and fluorescence intensity of the PNI model treated with k252a using IVIS spectrum in vivo imaging system ( n = 3/group); (B) representative images and quantitative analysis of the xenograft tumor in PNI models treated with k252a; (C) the clustering diagram of differentially expressed genes (DEGs) analyzed by transcriptome sequencing with xenograft tumor tissues from the k252a·PNI groups and PNI groups; (D) pathway analysis of downregulated DEGs using the GO database; (E and F) the mRNA expression levels of Akt in the PNI and k252a·PNI groups, CDX, and PNI groups using qRT-PCR; and (G–J) WB and quantitative analysis of the protein expression levels of Akt and pAkt in the PNI and k252a·PNI groups and the CDX and PNI groups at 40-, 50-, and 60-d. * p < 0.05, ** p < 0.01, and *** p < 0.001.

    Article Snippet: Recombined human BDNF protein (Cat#450-02), k252a (Cat#HY-N6732), and Deguelin (Cat#HY-13425) were obtained from PeproTech and Med Chem Express (MCE), respectively.

    Techniques: Fluorescence, In Vivo Imaging, Sequencing, Expressing, Quantitative RT-PCR